Maverick Capital’s Avanos Medical AVNS Stock Holding History

Maverick Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,898	Closed	-$336K	–	281
2024 Q1	$336K	Buy	16,898 +6,807	+67%	+$132K	0.01%	318
2023 Q4	$226K	Buy	+10,091	New	+$208K	﹤0.01%	324
2023 Q3	–	Sell	-12,863	Closed	-$329K	–	320
2023 Q2	$329K	Sell	12,863 -2,906	-18%	-$76.5K	0.01%	332
2023 Q1	$469K	Buy	+15,769	New	+$458K	0.01%	290
2022 Q4	–	Sell	-12,166	Closed	-$265K	–	385
2022 Q3	$265K	Buy	+12,166	New	+$318K	0.01%	253
2021 Q4	–	Sell	-5,107	Closed	-$159K	–	339
2021 Q3	$159K	Sell	5,107 -18,831	-79%	-$639K	﹤0.01%	549
2021 Q2	$871K	Buy	+23,938	New	+$990K	0.01%	329
2021 Q1	–	Sell	-35,372	Closed	-$1.62M	–	704
2020 Q4	$1.62M	Buy	+35,372	New	+$1.47M	0.03%	162

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Maverick Capital's AVNS Position: Q2 2024 in Review

Maverick Capital sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 16,898 shares — an estimated $336K sold.

Maverick Capital first reported a position in AVNS in Q4 2020 and held it in 8 quarters. The position peaked at $1.62M in Q4 2020. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

Maverick Capital reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
Maverick Capital sold 16,898 Avanos Medical shares in Q2 2024, an estimated $336K.
Maverick Capital first reported a position in Avanos Medical in Q4 2020 and held it in 8 quarters.
Maverick Capital's Avanos Medical position peaked at $1.62M in Q4 2020.
258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Maverick Capital's 13F filing for Q2 2024, filed 14 Aug 2024.